Home / Products / Continuous Aortic Monitoring

SphygmoCor Mx
 

Continuous Aortic Monitoring

 

Continuous Aortic Monitoring

The SphygmoCor Mx Aortic Blood Pressure Monitoring System extends the capabilities of the SphygmoCor Px system by providing continuous, real-time derivation of the aortic pressure waveform.

Key cardiovascular parameters are sampled every 5 seconds, and trended. These parameters include:

  • Central Systolic, Diastolic, and Pulse Pressures

  • Augmentation Index – a measure of the clinical impact of arterial stiffness on the heart

  • Ejection Duration – systolic timing, and hence an indicator of myocardial demand

  • Subendocardial Viability Ratio – a measure of cardiac reserve

The SphygmoCor Mx System also allows reports to be generated at regular intervals, or whenever required.

 

The SphygmoCor Mx system utilizes a continual radial artery pressure waveform input. This can be from either a radial artery catheter and BP monitor or a non-invasive radial artery pressure waveform monitor (calibrated or non-calibrated).

 

Benefits

The SphygmoCor Mx Aortic BP Monitoring System now makes it easier for you to monitor the "definitive" blood pressure – the pressure at the heart.

 

The system:

  • Monitors the complete aortic blood pressure profile that is seen by the left ventricle, the coronary arteries and the baro-receptors - not just the max/min pressure values seen in the radial artery.

  • Monitors central blood pressure – the pressure that drives the cerebral blood flow.

  • Tracks dynamic changes in LV load and subendocardial viability

  • Monitors subtle pressure waveform changes, not just max/min values of blood pressure.

Applications

  • Intensive Care (ICU)

  • Anesthesiology (OR)

  • Emergency Care

  • Research

Regulatory Status

  • IEC/EN 60601-1 (amendment 1 & 2) & IEC/EN 60601-1-2 (AS/NZS 3200.1.0 AS/NZS 3200.1.2) Electromedical Safety Certification (this is a mandatory requirement for medical equipment to be used in hospitals in some countries). Rating – “Type CF Class 2”

  • Device listing with the Australian Therapeutic Goods Administration (TGA)

  • CE Mark (MDD Annex II)

  • MLHW registration for Japan

  • KFDA Approval for Korea

  • Import License for China